Abstract:
Patient reported outcome (PRO) instruments are useful for collecting information from celiac disease patients, patients with gluten intolerance or gluten sensitivity, and patients on gluten free diets.
Abstract:
This invention relates to wort making for brewing and non alcoholic beverages. More particularly it relates to methods for preparing a wort comprising a high level of free amino acids employing use of various enzymes including different exogenous proteases, for example an endoprotease and an exopeptidase.
Abstract:
The present invention relates to a process for the preparation of a beverage comprising adding a proline-specific protease and a polyphenoloxidase to the beverage, and preparing the beverage, and a beverage obtainable by the process of the present invention.
Abstract:
Methods for diagnosing inflammatory and/or cardiovascular diseases by assaying for Fibroblast Activation Protein (FAP) expression in a body fluid is provided as well as therapeutic means based thereon.
Abstract:
A peptide preparation and processes for its preparation are described. Also uses thereof, and a feed composition containing the peptide preparation are described.
Abstract:
The present invention relates to a pasteurized food product having a water activity of at least 0.80, preferably at least 0.85 and containing a proline specific protease.
Abstract:
The invention relates to compounds with an antihypertensive effect. More in particular, the invention relates to releasing ACE (angiotensin I - converting enzyme)-inhibitory peptides from whey proteins. The invention provides a method for enzymatically producing a protein hydrolysate with angiotensin-converting enzyme (ACE)-inhibitory activity, characterized by treatment of a beta-lactoglobulin (BLG) -containing substrate with a broad-spectrum endoprotease in a first reaction step followed by treatment with a proline-specific endoprotease in a second reaction step. The invention also relates to ACE-inhibitory hydrolysates obtainable according to such a method and use of the hydrolysates.
Abstract:
The invention relates to a novel enzyme composition comprising Aspergillus oryza e prolyl endopeptidases having unique catalytic properties. The invention further relates to methods for producing the enzyme composition as well as a pharmaceutical composition and a food supplement containing the enzyme composition and its use in the degradation of polypeptides. The invention further relates to fungus Aspergillus oryzae strains deposited under accession number IHEM 26503 and IHEM 26504.
Abstract:
The present invention relates to a polypeptide having proline-specific endoprotease activity, wherein the polypeptide has less than 70% residual activity when the polypeptide has been kept at a temperature of 65°C for 15 min. The invention further relates to a polypeptide having proline-specific endoprotease activity comprising an amino acid sequence according to SEQ ID NO: 1, wherein SEQ ID NO: 1 comprises at least one amino acid substitution selected from the group consisting of M144L, S398F, V460A, I204F, Y205N, F279S, F263Y, P377A, L470P, and P477A, a nucleic acid encoding a polypeptide having proline-specific endoprotease activity, a method of making a variant polypeptide having proline-specific endoprotease activity, a recombinant host cell and a method of producing the polypeptide and a process for the preparation of a food or feed product wherein the polypeptide is used.
Abstract translation:本发明涉及具有脯氨酸特异性内切蛋白酶活性的多肽,其中当多肽已经在65℃的温度下保持15分钟时,多肽具有小于70%的残留活性。 本发明还涉及具有脯氨酸特异性内切蛋白酶活性的多肽,其包含根据SEQ ID NO:1的氨基酸序列,其中SEQ ID NO:1包含至少一个选自M144L,S398F,V460A的氨基酸取代 ,I204F,Y205N,F279S,F263Y,P377A,L470P和P477A,编码具有脯氨酸特异性内切蛋白酶活性的多肽的核酸,制备具有脯氨酸特异性内切蛋白酶活性的变体多肽的方法,重组宿主细胞和方法 以及制备其中使用多肽的食品或饲料产品的方法。